Further statistics show that 127 third quarter report pre Xi equity weeks are sought after by the mainstream funds on the market, with a total of 3.026 billion yuan. Among them, 57 three-quarter forecast stocks have accumulated net inflows of large single funds over 10 million yuan this week.
Specifically, six three-season forecast stock such as Muyuan Stock, Yupui Optics, Wens Stock, One-Net One-Chuang, East Hebei Cement and Zhifei Biology all received more than 100 million yuan this week. Ruida Futures, Yunda Stock, Royal Bank Stock, Wanji Science and Technology, Billion Networks, Chuangwei Digital, Kodaxunfei, Geer Stock, Jerry Stock, Xinghui Precision, Kerong Environment, Shanshi Net Section and other 12 three-quarter forecast shares during the cumulative net inflows of large single funds are also more than 50 million yuan. In addition, 39 three-quarter earnings forecast shares, including first voyage energy-saving, Xingqi Eye Drug, Golden Infrared, Probiotic Shares, Tianyu Shares and so on, also realized a large single capital sweep of more than 10 million yuan.
With the continued pursuit of funds, the stock prices of 127 stocks have generally performed well this week, with 122 three-quarter forecast stocks rising during the period, accounting for more than 90%. Among them, Tianshun Stock (46.47%), One Net One Creation (46.42%), Hongyu New Material (29.18%), Silicon Treasure Technology (25.72%), Xinghui Precision (24.90%), Friendship Group (22.15%), Wanji Technology (21.89%) and Dada Stock (20.67%) were among the top shareholders, all of which increased by more than 20%.
In addition to large single market funds favoring three-quarter forecast stocks, 90 three-quarter forecast stocks were favored by financiers in the three trading days from October 8 to October 10, with a total net financing purchase of 2.336 billion yuan. Among them, ZTE, Dahua Stock, Muyuan Stock, Haikang Weiwei and Gore Stock have accumulated net financing purchases of more than 100 million yuan during the period of five preferred shares. Zhonghuan, Ziguang Guowei, Kangtai Biology, Probiotics, Shanshi Networks, Yiwei Lithium Energy, Wentai Science and Technology, Watson Biology and other stocks have accumulated net financing purchases of more than 50 million yuan during the period.
It is worth mentioning that of the 320 three-quarter forecast stocks mentioned above, 6 of them have attracted the focus of northbound funds. This week, the total net purchases of northbound funds amounted to 2.398 billion yuan. Specifically, Haikangwei, Wens shares, Lixun Precision, Huiding Technologies and other four three-quarter forecast stock period, the total net purchases of funds from BeiShang reached more than 100 million yuan, and LiNeng and Tiger Pharmaceutical also realized the net purchases of funds from BeiShang during the three-quarter forecast stock period.